List of Amrix drug patents

Amrix is owned by Teva Pharms Intl.

Amrix contains Cyclobenzaprine Hydrochloride.

Amrix has a total of 8 drug patents out of which 0 drug patents have expired.

Amrix was authorised for market use on 01 February, 2007.

Amrix is available in capsule, extended release;oral dosage forms.

Amrix can be used as relief of muscle spasm.

The generics of Amrix are possible to be released after 26 February, 2025.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7829121 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(9 months from now)

US9375410 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(9 months from now)

US9399025 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(9 months from now)

US8877245 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(9 months from now)

US7544372 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(9 months from now)

US7820203 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(9 months from now)

US7790199 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(9 months from now)

US7387793 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Feb, 2025

(2 years from now)

Drugs and Companies using CYCLOBENZAPRINE HYDROCHLORIDE ingredient

Market Authorisation Date: 01 February, 2007

Treatment: Relief of muscle spasm

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

How can I launch a generic of AMRIX before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic